The Board of Directors meeting is scheduled for Monday, November 2, 2026. The primary agenda includes:
- Discussion, consideration, and approval of the unaudited standalone financial results for the half year ended September 30, 2026
- Discussion, consideration, and approval of the unaudited consolidated financial results for the half year ended September 30, 2026
- Review of the limited review report accompanying the financial results
- Any other business as approved by the Board
Additionally, the company has implemented a Trading Window Close Period in accordance with its code to regulate, monitor, and report trading by Directors, Promoters, Designated Employees, and Connected Persons. The trading restriction period commenced on October 1, 2026, and will conclude 48 hours after the financial results are made public following the board meeting on November 2, 2026.